Prosecution Insights
Last updated: April 19, 2026
Application No. 18/566,964

ELECTRODE DEVICE

Final Rejection §103§112
Filed
Dec 04, 2023
Examiner
TEHRANI, DANIEL
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
INBRAIN Neuroelectronics S.L.
OA Round
2 (Final)
58%
Grant Probability
Moderate
3-4
OA Rounds
3y 9m
To Grant
99%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allow Rate
28 granted / 48 resolved
-11.7% vs TC avg
Strong +44% interview lift
Without
With
+43.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
35 currently pending
Career history
83
Total Applications
across all art units

Statute-Specific Performance

§101
5.5%
-34.5% vs TC avg
§103
47.3%
+7.3% vs TC avg
§102
21.2%
-18.8% vs TC avg
§112
22.6%
-17.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 48 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment 2. This action is responsive to the amendments filed 2/19/2026. Claims 1, 4, 6-7, 11, and 14 have been amended. No claims were newly added or have been canceled. Response to Arguments 3. Applicant’s arguments with respect to the rejections under 35 USC 112(b) have been considered and are withdrawn in light of the amendments. 4. Applicant’s arguments filed on 2/19/2026 with respect to the art rejections have been fully considered but they are not persuasive. In substance, applicant argues that A) Dirk does not teach “a thin, flexible, selectively-conducting biocompatible polymer composite membrane or mat, including an array of pores through which neurons can grow” and B) Dirk does not teach planar electrodes that are “configured to detect neuron membrane activity or collective activity” and C) The claimed invention does not rely on the use of bioresorbable materials of any kind. 5. In response to A) the examiner respectfully disagrees. In response to applicant's argument that the references fail to show certain features of the invention, it is noted that the features upon which applicant relies (i.e., “a thin, flexible, selectively-conducting biocompatible polymer composite membrane or mat, including an array of pores through which neurons can grow”) are not recited in the rejected claim(s). Although the claims are interpreted in light of the specification, limitations from the specification are not read into the claims. See In re Van Geuns, 988 F.2d 1181, 26 USPQ2d 1057 (Fed. Cir. 1993). 6. In response to B) the examiner respectfully disagrees. In response to applicant's argument that the references fail to show certain features of the invention, it is noted that the features upon which applicant relies (i.e., planar electrodes that are “configured to detect neuron membrane activity or collective activity”) are not recited in the rejected claim(s). Although the claims are interpreted in light of the specification, limitations from the specification are not read into the claims. See In re Van Geuns, 988 F.2d 1181, 26 USPQ2d 1057 (Fed. Cir. 1993). 6. In response to C) the examiner respectfully disagrees. In response to applicant's argument that the references fail to show certain features of the invention, it is noted that the features upon which applicant relies (i.e., no use of bioresorbable materials of any kind) are not recited in the rejected claim(s). Although the claims are interpreted in light of the specification, limitations from the specification are not read into the claims. See In re Van Geuns, 988 F.2d 1181, 26 USPQ2d 1057 (Fed. Cir. 1993). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 3-7, 9-12, and 16-18 are rejected under 35 U.S.C 103 as being unpatentable over Dirk et al. (US Patent No.: 9,555,583 – Previously Cited) and further in view of Rogers et al. (US Pub.: 2011/0230747 A1 – Previously Cited). Regarding claim 1, Dirk teaches an electrode device for a neurostimulation system (e.g. column 8, lines 23-26, – neural interface both records and stimulate neural activity), comprising a substrate (e.g. Fig. 1B – polymer mat 11; column 8 lines 13-17) and at least one electrode (e.g. Fig. 1B – electrode site 15; column 8 lines 19-21) wherein the at least one electrode is arranged within the substrate (e.g. Fig. 1B – polymer mat 11, electrode site 15; column 7 lines 30-34). However, Dirk does not explicitly teach wherein a portion of the substrate comprises a mesh. Rogers, in a same field of endeavor of implantable medical devices, discloses wherein a portion of the substrate (e.g. Fig. 5B – 100(5)) comprises a mesh (e.g. Fig. 5B – layer 510; paragraphs 0036; 0129). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the electrode device of Dirk to have a portion of the substrate comprise a mesh, as taught and suggested by Rogers, in order to allow for more efficient handling and administration of the implantable device, while at the same time providing mechanical properties (e.g., flexibility, deformability, bendability, etc.) useful for establishing conformal contact with the target tissue (Rogers, paragraph 0036). Regarding claim 3, Dirk in view of Rogers teaches the electrode device according to claim 1 as discussed above, and Rogers further teaches wherein the mesh-like structure of the substrate comprises multiple voids of different sizes (e.g. paragraphs 0129; 0182), of different sizes (e.g. column 5, lines 6-11), wherein the device is configured for nerve stimulation and/or cortical stimulation and/or deep brain stimulation (e.g. paragraph 0045). Regarding claim 4, Dirk in view of Rogers teaches the electrode device according to claim 3 as discussed above, and Dirk further teaches wherein the voids comprise at least two different sizes of void, wherein each size is within the range of 10 mm to 0.1 µm (e.g. column 4, lines 54-67, column 3, lines 57-58, – the pores can have differing dimensions (e.g. diameter, length, width, etc). Regarding claim 5, Dirk in view of Rogers teaches the electrode device according to claim 3 as discussed above, and Rogers further teaches wherein the voids are symmetrically distributed along a cross-section of the substrate, in order to provide isotropic properties of the electrode device (e.g. Fig. 5b; paragraphs 0129-0130). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Dirk and Rogers to have the voids symmetrically distributed along a cross-section of the substrate, as taught and suggested by Rogers, in order to provide the predictable results of easier manufacturing of the device as it allows for easier quality control (i.e. visual inspecting that the voids on the substrate are symmetrical). Additionally, it would have been obvious to try choosing from a finite number of identified and predictable void arrangements with a reasonable expectation of success of more uniform electrical stimulation when in use. Regarding claim 6, Dirk in view of Rogers teaches the electrode device according to claim 3 as discussed above, and Dirk further teaches wherein the voids of the substrate comprise a circular shape, a triangular shape, a hexagonal shape, an octagonal shape, a rectangular shape, a parallelogram shape, and/or a squared shape (e.g. Fig. 1B – neural openings 12, – circular shape; column 8 lines 16-19). Regarding claim 7, Dirk in view of Rogers teaches the electrode device according to claim 1 as discussed above, and Dirk further teaches wherein the electrode device comprises at least one stimulation electrode and multiple recording electrodes (e.g. column 8, lines 22-25; column 10, lines 20-21). Regarding claim 9, Dirk in view of Rogers teaches the electrode device according to claim 1 as discussed above, and Dirk further teaches wherein the electrode device comprises multiple conductive connection elements, being positioned in and/or on the substrate for connecting each electrode with the conductive connector (e.g. Fig. 1B – electrical connectors 16; column 7 lines 65-66; column 8, lines 20-23). Regarding claim 10, Dirk in view of Rogers teaches the electrode device according to claim 9 as discussed above, and Rogers further teaches wherein each of the conductive connection elements are arranged along the voids of the substrate in a straight line between the voids, such that a connection angle between the conductive connection element and the conductive connector is the same for all conductive connection elements of the electrode device (e.g. paragraphs 0126, 0129). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Dirk and Rogers to incorporate having each of the conductive connection elements are arranged along the voids of the substrate in a straight line between the voids, such that a connection angle between the conductive connection element and the conductive connector is the same for all conductive connection elements of the electrode device, as taught and suggested by Rogers, for the purpose of improving the flexibility of the device (Rogers, paragraph 0126). Regarding claim 11, Dirk in view of Rogers teaches the electrode device according to claim 1 as discussed above, and Dirk further teaches wherein the electrode device comprises a circular outer shape, a triangular outer shape, a hexagonal outer shape, or an octagonal outer shape (e.g. Fig. 1B; column 8 lines 13-15). Regarding claim 12, Dirk in view of Rogers teaches the electrode device for a neurostimulation system, comprising a substrate and at least one electrode, wherein the at least one electrode is arranged within the substrate and wherein a portion of the substrate comprises a mesh (see rejection of claim 1 above). Additionally, Dirk further teaches an electrode module for a neurostimulation system comprising at least one electrode device (e.g. Fig. 1B; column 8 lines 13-20). Regarding claim 16, Dirk in view of Rogers teaches the electrode module according to claim 12 as discussed above, and Dirk further teaches wherein the electrode module comprises at least one sensor device being arranged at and/or along a void of the at least one electrode device such that the nervous tissue can be observed via the void by the sensor device (e.g. column 8, lines 19-27). Regarding claim 17, Dirk in view of Rogers teaches the electrode device for a neurostimulation system, comprising a substrate and at least one electrode, wherein the at least one electrode is arranged within the substrate and wherein a portion of the substrate comprises a mesh (see rejection of claim 1 above). Additionally, Dirk further teaches a neurostimulation system for nerve stimulation and/or cortical stimulation and/or deep brain stimulation (e.g. column 8 lines 19-25). Regarding claim 18, Dirk in view of Rogers teaches the electrode device for a neurostimulation system, comprising a substrate and at least one electrode, wherein the at least one electrode is arranged within the substrate and wherein a portion of the substrate comprises a mesh (see rejection of claim 1 above). Additionally, Dirk further teaches a method for manufacturing an electrode device and/or an electrode module and/or a neurostimulation system (e.g. column 10 lines 40-47). 9. Claim 2 is rejected under 35 U.S.C 103 as being unpatentable over Dirk and further in view of Rogers and further in view of Lu et al. (NPL reference, “Flexible Neural Electrode Array Based-on Porous Graphene for Cortical Microstimulation and Sensing”, published September, 2016 – Previously Cited). Regarding claim 2, Dirk in view of Rogers teaches the electrode device according to claim 1 as discussed above. However, Dirk in view of Rogers do not explicitly teach that the at least one electrode comprises graphene. Lu, in a same field of endeavor of electrical stimulation, discloses at least one electrode comprising graphene (e.g. pg. 2). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Dirk and Rogers to incorporate at least one electrode comprising graphene, as taught and suggested by Lu, in order to improve/enhance the conductivity, biocompatibility, and flexibility of the electrode (Lu, page 2). Claim 8 is rejected under 35 U.S.C 103 as being unpatentable over Dirk and further in view of Rogers and further in view of Wu et al. (US Pub.: 2022/0225921 A1 – Previously Cited). Regarding claim 8, Dirk in view of Rogers teaches the electrode device according to claim 1 as discussed above, and Dirk further teaches wherein the electrode device comprises at least one conductive connector, being situated along at least a part of the outer circumference of the electrode device (e.g. Fig. 1B; column 7 lines 65-66; column 8, lines 20-23). However, Dirk in view of Rogers do not explicitly teach that at least one conductive connector comprises gold. Wu, in a same field of endeavor of implantable medical devices, discloses at least one conductive connector comprising gold (e.g. paragraph 0059, – the electrode points, connection lines, and connection points can all comprise gold). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Dirk and Rogers to incorporate at least one conductive connector comprising gold, as taught and suggested by Wu, in order to improve/enhance the electrical conductivity, biocompatibility, and corrosion resistance of the electrode device. 11. Claim 13 is rejected under 35 U.S.C 103 as being unpatentable over Dirk and further in view of Rogers and further in view of Hauptmann et al. (US Pub.: 2022/0072313 A1 – Previously Cited). Regarding claim 13, Dirk in view of Rogers teaches the electrode module according to claim 12 as discussed above. However, Dirk in view of Rogers do not explicitly teach wherein multiple electrode devices are arranged side by side, wherein the multiple electrode devices each comprises a conductive connector, wherein the conductive connectors are combined in order to form a conductive connection expanding along and/or between the different electrode devices. Hauptmann, in a same field of endeavor of electrical stimulation devices, discloses multiple electrode devices arranged side by side, wherein the multiple electrode devices each comprises a conductive connector, wherein the conductive connectors are combined in order to form a conductive connection expanding along and/or between the different electrode devices (e.g. paragraph 0052). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Dirk and Rogers to include having multiple electrode devices arranged side by side, wherein the multiple electrode devices each comprises a conductive connector, wherein the conductive connectors are combined in order to form a conductive connection expanding along and/or between the different electrode devices, as taught and suggested by Hauptmann, in order to provide the predictable results of the physician being able to more easily provide electrical stimulation to two different areas/targets of the brain of the brain of the patient simultaneously. 12. Claims 14-15 are rejected under 35 U.S.C 103 as being unpatentable over Dirk and further in view of Rogers and further in view of Hauptmann and further in view of Page et al. (US Pub.: 2020/0269046 A1 – Previously Cited). Regarding claim 14, Dirk in view of Rogers teaches the electrode module according to claim 12 as discussed above. However, Dirk in view of Rogers do not explicitly teach wherein the electrode module comprises at least two electrode devices. Hauptmann, in a same field of endeavor of electrical stimulation devices, discloses wherein the electrode module comprises at least two electrode devices (e.g. paragraph 0052). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Dirk and Rogers to include having at least two electrode devices, as taught and suggested by Hauptmann, in order to provide the predictable results of the physician being able to more easily provide electrical stimulation to two different areas of the brain of the patient simultaneously. However, Dirk in view of Rogers in view of Hauptmann do not explicitly teach wherein a second electrode device is concentrically arranged at a longitudinal end of a first electrode device such that a multi-layer arrangement of electrode devices is provided. Page, in a same field endeavor of electrical stimulation devices, discloses wherein a second electrode device is concentrically arranged at a longitudinal end of a first electrode device such that a multi-layer arrangement of electrode devices is provided (e.g. paragraph 0240). Therefore, it would have been obvious to someone of ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination of Dirk, Rogers, and Hauptmann to incorporate a second electrode device being concentrically arranged at a longitudinal end of a first electrode device, as taught and suggested by Page, in order to maximize and direct the electric field and flow of current into the target nervous structure and without unwanted stimulation of nearby tissue (Page, paragraph 0240). Regarding claim 15, Dirk in view of Rogers in view of Hauptmann in view of Page teaches the electrode module according to claim 14 as discussed above, and Page further teaches wherein the at least one of the second electrode device is concentrically arranged with a void of the mesh-like structure of the first electrode device (Page, paragraph 0240). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DANIEL TEHRANI whose telephone number is (571)270-0697. The examiner can normally be reached 9:00am-5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Benjamin Klein can be reached at 571-270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /D.T./Examiner, Art Unit 3792 /Benjamin J Klein/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Dec 04, 2023
Application Filed
Nov 15, 2025
Non-Final Rejection — §103, §112
Feb 19, 2026
Response Filed
Mar 19, 2026
Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599764
HEADER ASSEMBLY HAVING CONTROLLED THERAPEUTIC AGENT RELEASE
2y 5m to grant Granted Apr 14, 2026
Patent 12558546
DORSAL ROOT GANGLION STIMULATION IN INFLUENCING ORGAN FUNCTION
2y 5m to grant Granted Feb 24, 2026
Patent 12539420
Deep Brain Stimulation Using Artificial Neural Networks
2y 5m to grant Granted Feb 03, 2026
Patent 12508432
Configurable Replacement Mechanism for Leadless Pacemaker System
2y 5m to grant Granted Dec 30, 2025
Patent 12502238
SURGICAL APPARATUS INCLUDING A STERILE ADAPTER HAVING MECHANICAL LOCKOUTS
2y 5m to grant Granted Dec 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
58%
Grant Probability
99%
With Interview (+43.8%)
3y 9m
Median Time to Grant
Moderate
PTA Risk
Based on 48 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month